A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database
Endocrine Journal · 2025 · 72 (3) · 273-283
DOI: 10.1507/endocrj.ej24-0286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Journal, 2025. Verfasst von Jie Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhangjiagang TCM Hospital, Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu 215600, China. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Hypoglycemic Agents, Diabetes Mellitus, Type 2, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Zhangjiagang TCM Hospital, Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu 215600, China.
- Department of Pharmacy, Taicang TCM Hospital, Affiliated to Nanjing University of Chinese Medicine, Taicang, Jiangsu 215400, China.
Zitieren
APA
Li, J., Xie, J., Han, Y., Zhang, W., Wang, Y., & Jiang, Z. (2025). A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database. Endocrine Journal, 72(3), 273-283. https://doi.org/10.1507/endocrj.ej24-0286
Vancouver
Li J, Xie J, Han Y, Zhang W, Wang Y, Jiang Z. A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database. Endocrine Journal. 2025;72(3):273-283. doi:10.1507/endocrj.ej24-0286
BibTeX
@article{Li2025,
author = {Li, Jie and Xie, Jun and Han, Yi and Zhang, Wei and Wang, Yilei and Jiang, Zhitao},
title = {A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database},
journal = {Endocrine Journal},
year = {2025},
volume = {72},
number = {3},
pages = {273--283},
doi = {10.1507/endocrj.ej24-0286}
}
EUVIMED